Neuropathy, Diabetic
19
2
2
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
1 terminated out of 19 trials
92.9%
+6.4% vs benchmark
5%
1 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes
Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation
Effect of a Combined Exercise Program on Neuropathic Pain and Perceived Quality of Life in Type 2 Diabetes
Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI.
Identification of Biomarkers for the Study of the Diabetic Foot and Evolution.
The Effect of Lacosamide in Peripheral Neuropathic Pain
Motor Learning in Individuals With Lower Limb Loss and Chronic Diabetes
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
Balance and Gait in Diabetic Neuropathy
Methods of Early Detection and Grading Of Diabetic Peripheral Neuropathy (MEDON)
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
Relaxation and Meditation Techniques on Pain, Fatigue and Quality of Life
DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
Assessments and Interventions for Hand Neuropathy in DM
Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)